Concepedia

Andreas Jekle

AJ

Statistics

Publications

35

Citations

2.4K

H-Index

24

Active since

1999

Affiliations

Roche (United States)(Current)

Rega Institute for Medical Research

KU Leuven

University of Tübingen

NovaBay Pharmaceuticals (United States)

Andreas Jekle is an author at Roche (United States) specializing in pharmacology, molecular virology, and life sciences.

ORCID

Publications per year

1999–2024

35

Publications

35

CD95 Signaling via Ceramide-rich Membrane Rafts

Heike Grassmé, Andreas Jekle, Andrea Riehle et al. · Journal of Biological Chemistry · 2001 · 628 citations · Full text

, , +17

A Novel Potassium Channel in Lymphocyte Mitochondria

Ildikò Szabó, Jürgen Bock, Andreas Jekle et al. · Journal of Biological Chemistry · 2005 · 223 citations · Full text

, , +17

Stimulation of CD95 (Fas) blocks T lymphocyte calcium channels through sphingomyelinase and sphingolipids

Albrecht Lepple‐Wienhues, Claus Belka, Tilmann Laun et al. · Proceedings of the National Academy of Sciences · 1999 · 178 citations

, , +17

The Substitutions L50F, E166A, and L167F in SARS-CoV-2 3CLpro Are Selected by a Protease Inhibitor <i>In Vitro</i> and Confer Resistance To Nirmatrelvir

Dirk Jochmans, Kim Donckers, Antitsa Stoycheva et al. · mBio · 2023 · 170 citations · Full text

, , +16

In Vivo Evolution of Human Immunodeficiency Virus Type 1 toward Increased Pathogenicity through CXCR4-Mediated Killing of Uninfected CD4 T Cells

Andreas Jekle, Oliver T. Keppler, Erik De Clercq et al. · Journal of Virology · 2003 · 126 citations · Full text

, , +13

1–5 of 35